Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- PMID: 38572751
- DOI: 10.3322/caac.21834
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Abstract
This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four-fold to five-fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South-Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics-based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.
Keywords: cancer burden; cancer control; epidemiology; incidence; mortality.
© 2024 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.
Similar articles
-
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. CA Cancer J Clin. 2018. PMID: 30207593
-
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. CA Cancer J Clin. 2021. PMID: 33538338
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516. Int J Cancer. 2010. PMID: 21351269
-
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. Eur J Cancer. 2018. PMID: 30100160 Review.
-
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.Lancet Oncol. 2022 Jun;23(6):719-728. doi: 10.1016/S1470-2045(22)00270-4. Epub 2022 May 9. Lancet Oncol. 2022. PMID: 35550275 Review.
Cited by
-
Time trend analysis and impacts of the COVID-19 pandemic on mammography and Papanicolaou test coverage in Brazilian state capitals.BMC Womens Health. 2024 Jul 31;24(1):436. doi: 10.1186/s12905-024-03278-7. BMC Womens Health. 2024. PMID: 39085895 Free PMC article.
-
Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregation.Oncol Lett. 2024 Jul 15;28(3):439. doi: 10.3892/ol.2024.14572. eCollection 2024 Sep. Oncol Lett. 2024. PMID: 39081965 Free PMC article.
-
Herbal Medicine-Derived Exosome-Like Nanovesicles: A Rising Star in Cancer Therapy.Int J Nanomedicine. 2024 Jul 25;19:7585-7603. doi: 10.2147/IJN.S477270. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39081899 Free PMC article. Review.
-
Mesoporous Graphene Oxide Nanocomposite Effective for Combined Chemo/Photo Therapy Against Non-Small Cell Lung Cancer.Int J Nanomedicine. 2024 Jul 24;19:7493-7508. doi: 10.2147/IJN.S460767. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39081895 Free PMC article.
-
Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer.J Transl Med. 2024 Jul 30;22(1):709. doi: 10.1186/s12967-024-05518-8. J Transl Med. 2024. PMID: 39080766 Free PMC article.
References
REFERENCES
-
- Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever‐increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029‐3030. doi:10.1002/cncr.33587
-
- Chen S, Cao Z, Prettner K, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465‐472. doi:10.1001/jamaoncol.2022.7826
-
- Guida F, Kidman R, Ferlay J, et al. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022;28(12):2563‐2572. doi:10.1038/s41591‐022‐02109‐2
-
- Ferlay J, Ervik M, Lam F, et al. eds, Global Cancer Observatory: Cancer Today (Version 1.0). International Agency for Research on Cancer; 2024. Accessed February 1, 2024. https://gco.iarc.who.int/today
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74‐108. doi:10.3322/canjclin.55.2.74
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical